Global Ophthalmic Viscosurgical Devices Market Growth 2023-2029

Global Ophthalmic Viscosurgical Devices Market Growth 2023-2029

Ophthalmic viscosurgical devices (OVDs) are used in cataract surgery as a viscoelastic solution to create and maintain space in the anterior chamber of the eye. OVDs have generally been used during phacoemulsification, implantation of intraocular lens, to protect corneal endothelium, and as a coating to surgical instruments. OVDs are transparent, gel like viscous substances having elastic properties. OVDs have properties of both fluids and solids. The differentiating feature in OVDs can be because of viscosity, pseudoplasticity, viscoelasticity, and coatability.

LPI (LP Information)' newest research report, the “Ophthalmic Viscosurgical Devices Industry Forecast” looks at past sales and reviews total world Ophthalmic Viscosurgical Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Ophthalmic Viscosurgical Devices sales for 2023 through 2029. With Ophthalmic Viscosurgical Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Viscosurgical Devices industry.

This Insight Report provides a comprehensive analysis of the global Ophthalmic Viscosurgical Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Viscosurgical Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ophthalmic Viscosurgical Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Viscosurgical Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Viscosurgical Devices.

The global Ophthalmic Viscosurgical Devices market size is projected to grow from US$ 1965.6 million in 2022 to US$ 2324.3 million in 2029; it is expected to grow at a CAGR of 2324.3 from 2023 to 2029.

United States market for Ophthalmic Viscosurgical Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Ophthalmic Viscosurgical Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Ophthalmic Viscosurgical Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Ophthalmic Viscosurgical Devices players cover Abbott Medical Optics, Carl-Zeiss, Novartis, Johnson & Johnson, Roche, Pfizer, Allergan, Hyaltech and Valeant Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Viscosurgical Devices market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Dispersive
Cohesive
Combined

Segmentation by application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Medical Optics
Carl-Zeiss
Novartis
Johnson & Johnson
Roche
Pfizer
Allergan
Hyaltech
Valeant Pharma
CIMA Technology
Rayner
Haohai Biological
Bausch & Lomb Inc.
Bloomage Biotechnology
Eyebright Medical
Imeik Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ophthalmic Viscosurgical Devices market?

What factors are driving Ophthalmic Viscosurgical Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ophthalmic Viscosurgical Devices market opportunities vary by end market size?

How does Ophthalmic Viscosurgical Devices break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.